{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:21:21Z","timestamp":1778671281288,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003425","name":"Departamento de Educaci\u00f3n, Gobierno de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007727","name":"Department of Industry, Innovation\u00a0and Science, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.canlet.2019.11.016","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T20:05:16Z","timestamp":1573848316000},"page":"490-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Telomerase-specific attenuated viruses, a definitive strategy or just one more in circulating tumor cells detection anthology?"],"prefix":"10.1016","volume":"469","author":[{"given":"Elena","family":"Soria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miren","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-1053","authenticated-orcid":false,"given":"Natalia","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.11.016_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2018.03.027","article-title":"The identification and isolation of CTC: a biological Rubik's cube","volume":"126","author":"Mansilla","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"46","key":"10.1016\/j.canlet.2019.11.016_bib2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1039\/C6CS00803H","article-title":"Current detection technologies of circulating tumor cells","volume":"18","author":"Shen","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.canlet.2019.11.016_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1479-5876-9-70","article-title":"Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients","volume":"9","author":"Liu","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2019.11.016_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13045-019-0735-4","article-title":"Technologies for circulating tumor cell separation from whole blood","volume":"12","author":"Bank\u00f3","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2019.11.016_bib5","doi-asserted-by":"crossref","DOI":"10.1063\/1.4922081","article-title":"Deformability-based circulating tumor cell separation with conical-shaped microfilters: concept, optimization, and design criteria","volume":"9","author":"Aghaamoo","year":"2015","journal-title":"Biomicrofluidics"},{"issue":"1","key":"10.1016\/j.canlet.2019.11.016_bib6","doi-asserted-by":"crossref","DOI":"10.1063\/1.4774312","article-title":"Separation of tumor cells with dielectrophoresis-based microfluidic chip","volume":"7","author":"Alshareef","year":"2013","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.canlet.2019.11.016_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nprot.2017.125","article-title":"Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device","volume":"13","author":"Khoo","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2019.11.016_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep42517","article-title":"Enrichment of circulating head and neck tumour cells using spiral microfluidic technology","volume":"7","author":"Kulasinghe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.11.016_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1078-0432.CCR-16-0825","article-title":"Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high circulating tumor cell counts","volume":"23","author":"Shaw","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.016_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy","volume":"6","author":"Alix-Panabi\u00e8res","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2019.11.016_bib11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.molonc.2016.07.005","article-title":"Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer","volume":"10","author":"Gasch","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.canlet.2019.11.016_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1373\/clinchem.2014.222331","article-title":"Genomic high-resolution profiling of single CKpos\/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer","volume":"60","author":"Neves","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2019.11.016_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/gm510","article-title":"Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS","volume":"5","author":"Swennenhuis","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2019.11.016_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201010021","article-title":"Circulating tumor cells: approaches to isolation and characterization","volume":"192","author":"Yu","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2019.11.016_bib15","first-page":"971","article-title":"Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients","volume":"5","author":"Soria","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.016_bib16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"issue":"6808","key":"10.1016\/j.canlet.2019.11.016_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/35040500","article-title":"Telomere states and cell fates","volume":"408","author":"Blackburn","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2019.11.016_bib18","doi-asserted-by":"crossref","first-page":"21892","DOI":"10.18632\/oncotarget.5260","article-title":"Dissecting tumor metabolic heterogeneity: telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells","volume":"8","author":"Lamb","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.canlet.2019.11.016_bib19","doi-asserted-by":"crossref","first-page":"20667","DOI":"10.18632\/oncotarget.15400","article-title":"NADH autofluorescence, a new metabolic biomarker for cancer stem cells: identification of Vitamin C and CAPE as natural products targeting \u201cstemness\u201d","volume":"28","author":"Bonuccelli","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.canlet.2019.11.016_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11060-018-2912-7","article-title":"TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas","volume":"139","author":"Biczok","year":"2018","journal-title":"J. Neuro Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2019.11.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-018-03067-x","article-title":"The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis","volume":"142","author":"Lu","year":"2019","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2019.11.016_bib22","article-title":"Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review","volume":"20","author":"St\u00f6gbauer","year":"2019","journal-title":"Neurosurg. Rev."},{"issue":"10","key":"10.1016\/j.canlet.2019.11.016_bib23","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/mc.22388","article-title":"Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology","volume":"55","author":"de Martino","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.canlet.2019.11.016_bib24","first-page":"491","article-title":"New evidence of TERT rs2736098 polymorphism and cancer risk: an updated meta-analysis","volume":"21","author":"Li","year":"2016","journal-title":"J BUON"},{"issue":"8","key":"10.1016\/j.canlet.2019.11.016_bib25","article-title":"Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis","volume":"19","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.canlet.2019.11.016_bib26","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.21873\/anticanres.13657","article-title":"Characterization of telomerase (hTERT) in solid and hematopoietic cancer cell lines reveals different expression patterns","volume":"39","author":"DE Holanda","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.11.016_bib27","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI38609","article-title":"A simple biological imaging system for detecting viable human circulating tumor cells","volume":"119","author":"Kojima","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2019.11.016_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-011-1603-2","article-title":"A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients","volume":"128","author":"Kim","year":"2011","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2019.11.016_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/bjc.2012.276","article-title":"Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers","volume":"107","author":"Takakura","year":"2012","journal-title":"Br. J. Canc."},{"issue":"Issue suppl_4","key":"10.1016\/j.canlet.2019.11.016_bib30","doi-asserted-by":"crossref","first-page":"iv505","DOI":"10.1093\/annonc\/mdu354.36","article-title":"1447P. A detection system for circulating tumor cells (CTC) using GFP expressing telomerase-specific replication-competent adenovirus in bone and soft tissue sarcoma","volume":"25","author":"Kunisada","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.11.016_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4161\/cbt.28412","article-title":"Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study","volume":"15","author":"Ju","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2019.11.016_bib32","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1158\/0008-5472.CAN-13-0813","article-title":"Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay","volume":"74","author":"Macarthur","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.016_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2407-12-346","article-title":"Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study","volume":"12","author":"Ito","year":"2012","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2019.11.016_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3892\/ijo.2014.2409","article-title":"Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients: a prospective study","volume":"45","author":"Ito","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.11.016_bib35","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3892\/or.2014.3436","article-title":"Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus","volume":"3","author":"Yabusaki","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2019.11.016_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/pros.22845","article-title":"A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector","volume":"74","author":"Wu","year":"2014","journal-title":"The Prostate"},{"key":"10.1016\/j.canlet.2019.11.016_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cncr.28975","article-title":"Tracking viable circulating tumor cells (CTC) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results","volume":"121","author":"Dorsey","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2019.11.016_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/gutjnl-2014-306957","article-title":"Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics","volume":"64","author":"Shigeyasu","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2019.11.016_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1535-7163.MCT-14-0693","article-title":"A combinatory strategy for detection of live CTC using microfiltration and a new telomerase-selective adenovirus","volume":"14","author":"Ma","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2019.11.016_bib40","article-title":"A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.11.016_bib41","doi-asserted-by":"crossref","first-page":"39768","DOI":"10.18632\/oncotarget.9465","article-title":"Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.016_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.1","article-title":"Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus","volume":"3","author":"Sakurai","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.canlet.2019.11.016_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2015.12.018","article-title":"Ad5\/35E1aPSESE4: a novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA\/PSMA transcription regulatory elements","volume":"372","author":"Hwang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.016_bib44","doi-asserted-by":"crossref","first-page":"34884","DOI":"10.18632\/oncotarget.16818","article-title":"Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients","volume":"8","author":"Togo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.016_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cas.13449","article-title":"Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells","volume":"109","author":"Takakura","year":"2018","journal-title":"Cancer Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:48:21Z","timestamp":1759592901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519305713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"alternative-id":["S0304383519305713"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomerase-specific attenuated viruses, a definitive strategy or just one more in circulating tumor cells detection anthology?","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}